SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Gliatech (GLIA)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jeffbas who wrote (1388)2/27/2000 5:16:00 PM
From: Torben Noerup Nielsen   of 2001
 
Jeffrey,

As pointed out by several surgeons, tearing the dura is not all that easy. It's evolved to be *tough* for good reason and I'm convinced that dural tears are primarily caused by incompetent surgeons. And ADCON use is *not* indicated in cases where there are dural tears.

Patient lawsuits are a matter of course. Yes, I'm biased, but I find it hard to imagine a medical supplies company that doesn't have at least one patient lawsuit pending at any given time. That's part of the cost of doing business. Moreover, I believe such suits are usually settled if there's any merit at all.

And given the increased FDA scrutiny, is it really likely that there's a big smoking gun here?

Finally, there's ADCON-A and the biotechnology side of the company which *still* isn't priced in at all.

I think I'm going to start daytrading this one for a fraction of a point here and there. As far as I can tell, it appears to be basing.

Thanks, Torben
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News